Project Grant R21NS142639
- Federal Grant Award Summary Emory University received a $234,750 Project Grant from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853), effective August 1, 2025, through July 31, 2027. The project focuses on developing instantaneous digital subtraction angiography (DSA) technology for neurovascular applications to address cerebrovascular disease (CVD), which ranks as...
- Federal Project Grant Award Summary Emory University received a $577,611 Project Grant from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853), awarded January 23, 2026, with completion targeted for December 31, 2030. The grant funds research investigating the cellular mechanisms underlying resting-state functional magnetic resonance imaging (RS-fMRI) patterns in the...
- Federal Project Grant Award Summary The National Institute of Neurological Disorders and Stroke (NINDS) awarded J. David Gladstone Institutes a Project Grant of $1,375,478 under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853), effective September 1, 2025, through August 31, 2033. This eight-year award supports multidisciplinary research investigating neurovascular dysfunction and its role in neurodegeneration, central nervous system (CNS)...
- Grant Award Summary The National Institute of Neurological Disorders and Stroke (NINDS), under its Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853), awarded $1,458,330 to the Regents of the University of Minnesota, effective August 1, 2025 through April 30, 2030. The research project will employ advanced neuroimaging techniques—including three-photon optical imaging, two-photon optogenetics, and two-photon photothrombosis—to characterize neurovascular...
- Federal Grant Award Summary Emory University received a $430,375 Project Grant from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, effective July 1, 2025 through June 30, 2027. The award funds research to elucidate the mechanisms of altered RNA transport dynamics caused by KIF1C (Kinesin-3 motor protein) mutations in heterospastic paraplegia type 58 (SPG58), a...
- Federal Project Grant Award Summary The University of Pennsylvania received a $664,458 Project Grant from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853), effective September 1, 2025, through August 31, 2030. This award supports the development and validation of a novel optical imaging technology for prehospital detection of large vessel occlusion (LVO) in acute stroke...
- Federal Project Grant Award Summary Emory University received a $540,901 Project Grant from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853), awarded April 15, 2026, with completion targeted for March 31, 2031. The grant funds basic neuroscience research investigating changes in dopamine signaling mechanisms in advanced Parkinson's disease, with focus on understanding...
- Federal Grant Award Summary Vanderbilt University Medical Center received a $338,232 Project Grant award effective August 1, 2025, through September 31, 2030, from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853). The project aims to develop a novel machine learning platform that generates partially synthetic Chemical Exchange Saturation Transfer (CEST) data to...
- Federal Grant Award Summary The University of Virginia received a $242,250 Project Grant awarded February 1, 2026, by the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853). The award supports a two-year research initiative (through January 31, 2028) investigating myeloid cell regulation of cerebrovascular tone and blood flow in the brain. The research employs longitudinal in...
- Federal Project Grant Award Summary The National Institute of Neurological Disorders and Stroke (NINDS) awarded The Ohio State University $433,125 on May 1, 2026, under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853) to develop and optimize a three-dimensional Total Internal Reflection Fluorescence Structured Illumination Microscope (3D TIRF-SIM). This instrument represents an advancement in super-resolution imaging technology designed to...
Emory University received a $430,375 Project Grant from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853), awarded on June 22, 2026, with completion targeted for May 31, 2028. The research initiative focuses on developing X-ray dark-field imaging technology enhanced by anisotropic iron oxide nanorods to analyze carotid hemodynamics and cerebrovascular disease. This project addresses a critical clinical need by advancing imaging capabilities to measure wall shear rate, wall shear stress, and wall shear oscillation at the carotid bifurcation—key hemodynamic parameters for predicting plaque vulnerability, identifying intervention candidates, and assessing therapeutic efficacy. The project leverages grating-based interferometric X-ray imaging combined with rod-shaped iron oxide nanoparticles as contrast agents to generate substantially larger dark-field signals compared to conventional attenuation-based imaging methods. By exploiting the orientation-dependent properties of anisotropic nanoparticles in vascular flow, the research aims to create a clinically viable imaging modality capable of visualizing flow patterns in cerebrovascular structures with enhanced sensitivity and specificity. This innovation represents a translational advance toward clinical application of a novel neuroimaging technology that could significantly improve cerebrovascular disease assessment and patient care outcomes.Federal Project Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $430.4k | 6/23/26 |